G
Gopala Reddy Palnati
Researcher at Central Drug Research Institute
Publications - 23
Citations - 474
Gopala Reddy Palnati is an academic researcher from Central Drug Research Institute. The author has contributed to research in topics: Aryl & One-pot synthesis. The author has an hindex of 12, co-authored 23 publications receiving 410 citations.
Papers
More filters
Journal ArticleDOI
Discovery of coumarin-monastrol hybrid as potential antibreast tumor-specific agent.
Koneni V. Sashidhara,Srinivasa Rao Avula,Komal Sharma,Gopala Reddy Palnati,Surendar Reddy Bathula +4 more
TL;DR: A novel class of coumarin-monastrol hybrid is discovered, as a novel breast cancer agent which selectively induce apoptosis in both primary and metastatic breast cancer cell lines.
Journal ArticleDOI
Molecular iodine catalysed one-pot synthesis of chromeno[4,3-b]quinolin-6-ones under microwave irradiation
Koneni V. Sashidhara,Gopala Reddy Palnati,L. Ravithej Singh,Amit Upadhyay,Srinivasa Rao Avula,Abdhesh Kumar,Ruchir Kant +6 more
TL;DR: A facile one pot approach for the regioselective synthesis of chromeno[4,3-b]quinolin-6-one derivatives in excellent yields under microwave (MW) irradiation is demonstrated.
Journal ArticleDOI
Coumarin–benzimidazole hybrids as a potent antimicrobial agent: synthesis and biological elevation
L. Ravithej Singh,Srinivasa Rao Avula,Sneha Raj,Akanksha Srivastava,Gopala Reddy Palnati,C. K. M. Tripathi,Mukesh Pasupuleti,Koneni V. Sashidhara +7 more
TL;DR: In this paper, a series of coumarin-benzimidazole hybrids were designed, synthesized and evaluated for their broad spectrum antimicrobial activity, which showed the most promising broad spectrum antibacterial activity against Pseudomonas aeruginosa, Staphylococcus aureus, Bacillus subtilis and Proteus vulgaris.
Journal ArticleDOI
Coumarin chalcone fibrates: a new structural class of lipid lowering agents.
Koneni V. Sashidhara,Gopala Reddy Palnati,Ravi Sonkar,Srinivasa Rao Avula,Chetan Awasthi,Gitika Bhatia +5 more
TL;DR: Structurally interesting coumarin-chalcone fibrates synthesized and evaluated in triton WR-1339 induced hyperlipidemic rats suggest that these novel hybrids would be a potential new class of therapeutic agents against dyslipidemia.